Current and Future Applications of Fluorescence-Guided Surgery in Head and Neck Cancer

Vigneswaran N. Williams M.D.

Epidemiologic trends in head and neck cancer and aids in diagnosis.

Oral Maxillofac Surg Clin North Am. 26: 123-141Pollock N.I. Grandis J.R.

HER2 as a therapeutic target in head and neck squamous cell carcinoma.

Clin Cancer Res. 21: 526-533Eldeeb H. Macmillan C. Elwell C. et al.

The effect of the surgical margins on the outcome of patients with head and neck squamous cell carcinoma: single institution experience.

Cancer Biol Med. 9: 29-33Li M.M. Puram S.V. Silverman D.A. et al.

Margin analysis in head and neck cancer: state of the art and future directions.

Ann Surg Oncol. 26: 4070-4080van Keulen S. Nishio N. Fakurnejad S. et al.

Intraoperative tumor assessment using real-time molecular imaging in head and neck cancer patients.

J Am Coll Surg. 229: 560-567.e561Mieog J.S.D. Achterberg F.B. Zlitni A. et al.

Fundamentals and developments in fluorescence-guided cancer surgery.

Nat Rev Clin Oncol. 19: 9-22Tanyi J.L. Chon H.S. Morgan M.A. et al.

Phase 3, randomized, single-dose, open-label study to investigate the safety and efficacy of pafolacianine sodium injection (OTL38) for intraoperative imaging of folate receptor positive ovarian cancer.

J Clin Oncol. 39: 5503

StatPearls.

StatPearls Publishing Copyright © 2022, StatPearls Publishing LLC., Bryan Bell R. Fernandes R.P. Andersen P.E. Oral, head and neck oncology and reconstructive surgery. Elsevier, : 107-118Hoffmann E.J. Phelps M.E. Mullani N.A. et al.

Design and performance characteristics of a whole-body positron transaxial tomograph.

J Nucl Med. 17: 493-502Fletcher J.W. Djulbegovic B. Soares H.P. et al.

Recommendations on the Use of 18F-FDG PET in oncology.

J Nucl Med. 49: 480

Use of PET/CT scanning in cancer patients: technical and practical considerations.

Proc (Bayl Univ Med Cent). 18: 321-330Kapoor V. McCook B.M. Torok F.S.

An Introduction to PET-CT Imaging.

RadioGraphics. 24: 523-543

Targeted optical imaging agents in cancer: focus on clinical applications.

Contrast Media Mol Imaging. : 2015237https://doi.org/10.1155/2018/2015237

A short history of sonography in obstetrics and gynaecology.

Facts Views Vis Obgyn. 5: 213-229

The application of ultrasound image in cancer diagnosis.

J Healthc Eng. 2021: 8619251Carovac A. Smajlovic F. Junuzovic D.

Application of ultrasound in medicine.

Acta Inform Med. 19: 168-171de Boer E. Harlaar N.J. Taruttis A. et al.

Optical innovations in surgery.

Br J Surg. 102: e56-e72Stewart H.L. Birch D.J.S.

Fluorescence guided surgery.

Methods Appl Fluorescence. 9: 042002Gioux S. Choi H.S. Frangioni J.V.

Image-guided surgery using invisible near-infrared light: fundamentals of clinical translation.

Mol Imaging. 9: 237-255Lee Y.J. Krishnan G. Nishio N. et al.

Intraoperative fluorescence-guided surgery in head and neck squamous cell carcinoma.

Laryngoscope. 131: 529-534Schaafsma B.E. Mieog J.S.D. Hutteman M. et al.

The clinical use of indocyanine green as a near-infrared fluorescent contrast agent for image-guided oncologic surgery.

J Surg Oncol. 104: 323-332Zhang R.R. Schroeder A.B. Grudzinski J.J. et al.

Beyond the margins: real-time detection of cancer using targeted fluorophores.

Nat Rev Clin Oncol. 14: 347-364Crawford K.L. Pacheco F.V. Lee Y.-J. et al.

A scoping review of ongoing fluorescence-guided surgery clinical trials in otolaryngology.

Laryngoscope. 132: 36-44

Fluorescence image-guided surgery - a perspective on contrast agent development.

Proc SPIE Int Soc Opt Eng. 11222: 112220Jvan Manen L. Handgraaf H.J.M. Diana M. et al.

A practical guide for the use of indocyanine green and methylene blue in fluorescence-guided abdominal surgery.

J Surg Oncol. 118: 283-300

Relieving the pain of sentinel lymph node biopsy tracer injection.

Clin J Oncol Nurs. 12: 668-670Hadjipanayis C.G. Stummer W.

5-ALA and FDA approval for glioma surgery.

J Neurooncol. 141: 479-486Malmström P.-U. Hedelin H. Thomas Y.K. et al.

Fluorescence-guided transurethral resection of bladder cancer using hexaminolevulinate: analysis of health economic impact in Sweden.

Scand J Urol Nephrol. 43: 192-198Zhou H. Gao Y. Liu Y. et al.

Targeted fluorescent imaging of a novel FITC-labeled PSMA ligand in prostate cancer.

Amino Acids. 54: 147-155Mahalingam S.M. Kularatne S.A. Myers C.H. et al.

Evaluation of novel tumor-targeted near-infrared probe for fluorescence-guided surgery of cancer.

J Med Chem. 61: 9637-9646de la Torre B.G. Albericio F.

The Pharmaceutical Industry in 2021. An Analysis of FDA Drug Approvals from the Perspective of Molecules.

Molecules. 27https://doi.org/10.3390/molecules27031075Heath C.H. Deep N.L. Sweeny L. et al.

Use of panitumumab-IRDye800 to image microscopic head and neck cancer in an orthotopic surgical model.

Ann Surg Oncol. 19: 3879-3887Gao R.W. Teraphongphom N. de Boer E. et al.

Safety of panitumumab-IRDye800CW and cetuximab-IRDye800CW for fluorescence-guided surgical navigation in head and neck cancers.

Theranostics. 8: 2488-2495Samkoe K.S. Gunn J.R. Marra K. et al.

Toxicity and pharmacokinetic profile for single-dose injection of ABY-029: a fluorescent Anti-EGFR synthetic affibody molecule for human use.

Mol Imaging Biol. 19: 512-521Sun Y. Zeng X. Xiao Y. et al.

Novel dual-function near-infrared II fluorescence and PET probe for tumor delineation and image-guided surgery.

Chem Sci. 9: 2092-2097Handgraaf H.J.M. Boonstra M.C. Prevoo H.A.J.M. et al.

Real-time near-infrared fluorescence imaging using cRGD-ZW800-1 for intraoperative visualization of multiple cancer types.

Oncotarget. 8: 21054-21066Witjes M. Voskuil F. Steinkamp P. et al.

Fluorescence guided surgery using the pH-activated micellar tracer ONM-100: first-in-human proof of principle in head and neck squamous cell carcinoma.

J Oral Maxillofacial Surg. 77: e38https://doi.org/10.1016/j.joms.2019.06.061Irwin C.P. Portorreal Y. Brand C. et al.

PARPi-FL--a fluorescent PARP1 inhibitor for glioblastoma imaging.

Neoplasia. 16: 432-440van Oosten M. Crane L.M. Bart J. et al.

Selecting potential targetable biomarkers for imaging purposes in colorectal cancer using target selection criteria (TASC): a novel target identification tool.

Transl Oncol. 4: 71-82Bossi P. Resteghini C. Paielli N. et al.

Prognostic and predictive value of EGFR in head and neck squamous cell carcinoma.

Oncotarget. 7: 74362-74379Kossatz S. Brand C. Gutiontov S. et al.

Detection and delineation of oral cancer with a PARP1 targeted optical imaging agent.

Sci Rep. 6: 21371Srinivasarao M. Galliford C.V. Low P.S.

Principles in the design of ligand-targeted cancer therapeutics and imaging agents.

Nat Rev Drug Discov. 14: 203-219Becker A. Hessenius C. Licha K. et al.

Receptor-targeted optical imaging of tumors with near-infrared fluorescent ligands.

Nat Biotechnol. 19: 327-331Whitley M.J. Cardona D.M. Lazarides A.L. et al.

A mouse-human phase 1 co-clinical trial of a protease-activated fluorescent probe for imaging cancer.

Sci Transl Med. 8: 320ra324Steinkamp P. Voskuil F. van der Vegt B. et al.

Metabolic acidosis in cancer: a new strategy using a ph activated imaging agent for fluorescence-guided surgery in humans.

Eur J Surg Oncol. 46: e163-e164https://doi.org/10.1016/j.ejso.2019.11.433Gorpas D. Phipps J. Bec J. et al.

Autofluorescence lifetime augmented reality as a means for real-time robotic surgery guidance in human patients.

Scientific Rep. 9: 1187Krishnan G. van den Berg N.S. Nishi N. et al.

Fluorescent molecular imaging can improve intraoperative sentinel margin detection in oral squamous cell carcinoma.

J Nucl Med. 121: 262235Leal Ghezzi T. Campos Corleta O.

30 years of robotic surgery.

World J Surg. 40: 2550-2557Couey M. Patel A. Bell R.B. Acero J. Innovations and new developments in craniomaxillofacial reconstruction. Springer International Publishing, : 199-210Lee Y.-J. van den Berg N.S. Orosco R.K. et al.

A narrative review of fluorescence imaging in robotic-assisted surgery.

Laparosc Surg. 5: 31

Rao, S., Stone, L.D., Jeyarajan H. et al., Standardized Fluorescence-Guided TORS Using An Integrated Signal Source. Poster presented at: The AHNS Annual Meeting; April 27-28, 2022; Dallas, TX.

Povoski S.P. Neff R.L. Mojzisik C.M. et al.

A comprehensive overview of radioguided surgery using gamma detection probe technology.

World J Surg Oncol. 7: 11Mariani G. Valdés Olmos R.A. Vidal-Sicart S. et al.

Radioguided surgery.

J Nucl Med. 62: 591

留言 (0)

沒有登入
gif